Catalyst Wire Dossier Catalyst Wire Dossier

Peginterferon alfa-2b (Pegasys)

pegylated interferon alfa-2b · Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Peginterferon alfa-2b (Pegasys), covering 2008-01-21 to 2008-01-21. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection [Phase 2]

See pricing